hat
Masteron possède anti estrogenic pwopwiyete ki rezilta yo nan eliminasyon anpil nan yo te sipèfli lòt efè sou kote ki jan moun ka eksperyans, tankou gynecomastia, ak dlo enbe ak danjere yo ogmante tansyon nan. Malgre ke Masteron, ki se yon stewoyid fèb ak sou papye, li gen ti pwopwiyete androgenic, li te deja te mansyone nan pratik pwopwiyete androgenic yo sanble yon ti jan pi wo pase nan teori, ak Dezyèmman Masteron se yon DHT dérivés. Pou pi detaye sou enfòmasyon sou DHT ak rezilta an plis DHT nan sikilasyon gade seksyon ' posib lòt efè sou kote ' a atik òmòn gason tankou yon stewoyid ou.
eng
Masteron possesses anti-estrogenic properties which results in the elimination of many of the unwanted side effects that AS users may experience, such as gynecomastia, water retention and dangerous increases in blood pressure. Although Masteron is a weak steroid and on paper it has low androgenic properties, it has already been mentioned that in practice the androgenic properties appear to be slightly higher than in theory, and secondly Masteron is a DHT derivative. For more detailed information on DHT and the results of excess DHT in circulation see the 'Possible Side Effects' section of the article Testosterone as an Anabolic Steroid.